COPT Defense Properties (NYSE:CDP) Declares Quarterly Dividend of $0.32

COPT Defense Properties (NYSE:CDP) announced a quarterly dividend on Thursday, August 13th. Shareholders of record on Wednesday, September 30th will be paid a dividend of 0.32 per share on Thursday, October 15th. This represents a c) annualized dividend and a yield of 3.4%. The ex-dividend date is Wednesday, September 30th.

COPT Defense Properties has increased its dividend by an average of 0.0%annually over the last three years.

COPT Defense Properties Trading Up 0.8%

NYSE CDP opened at $37.26 on Friday. COPT Defense Properties has a 1 year low of $27.06 and a 1 year high of $38.90. The company has a debt-to-equity ratio of 1.64, a current ratio of 2.89 and a quick ratio of 2.89. The company has a market capitalization of $4.23 billion, a PE ratio of 25.88 and a beta of 0.76. The company has a fifty day moving average of $36.24 and a 200 day moving average of $33.31.

COPT Defense Properties (NYSE:CDP) last released its quarterly earnings data on Monday, July 27th. The company reported $0.40 earnings per share for the quarter, beating analysts’ consensus estimates of $0.33 by $0.07. COPT Defense Properties had a return on equity of 10.48% and a net margin of 20.94%.The business had revenue of $197.39 million during the quarter, compared to analyst estimates of $189.36 million. During the same quarter last year, the business posted $0.34 EPS. COPT Defense Properties has set its FY 2026 guidance at 1.390-1.430 EPS and its Q3 2026 guidance at 0.370-0.390 EPS. Research analysts forecast that COPT Defense Properties will post 2.78 earnings per share for the current year.

About COPT Defense Properties

COPT Defense Properties (NYSE: CDP) is a real estate investment trust organized to own, lease and manage healthcare and life science facilities serving the United States federal government, with a particular focus on Department of Defense and Veterans Affairs tenants. The company was formed in 2016 through a spin-off from Corporate Office Properties Trust, enabling it to concentrate exclusively on medical office buildings and specialized research facilities situated on or near military and federal research campuses.

The company’s portfolio comprises purpose-built, Class A medical office and outpatient specialty clinics, as well as life science laboratories.